Dietary modifications, nutritional supplements and alternative medicine in paediatric patients with inflammatory bowel disease

Gerasimidis, Konstantinos; McGrogan, Paraic; Hassan, Kamal; Edwards, Christine

doi:10.1111/j.1365-2036.2007.03552.x

Cited by 42 publications

(48 citation statements)

References 52 publications

(181 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The prominence of social networks as the main CAM information source is noted particularly, but not exclusively, in the UK [5,7,29,35,36,[54][55][56][57][58][59], Turkey [38,39,41,42,[60][61][62][63][64][65], Israel [66][67][68], Norway [11] and Ireland [69], and is confirmed by studies examining CAM across a range of countries [33,[70][71][72][73]. Citizens in these countries appear to draw considerably less frequently on biomedical professionals for information about CAM.…”

Section: Citizens' Information Sources About Cammentioning

confidence: 72%

“…Citizens' stance as critical consumers is also noticeable with regard to the safety of CAM, as citizens do not automatically assume the safety and quality of CAM provision [54,79]. Although studies show that many citizens across Europe perceive CAM and/or CAM products as 'natural' and, therefore, safer than biomedical treatment, and/or as not involving risk and/or side-effects [7,16,28,32,35,43,44,46,50,61,62,64,78,79,91,120,121,[124][125][126][127][128][129][130][131][132], several of these studies also indicate that citizens are critical, and at times doubtful, about CAM safety and efficacy [16,79,130,131]. The historical use of acupuncture and herbal medicine is particularly argued to explain their safety [16,75].…”

Section: Citizens' Information Sources About Cammentioning

confidence: 99%

“…general practitioners, hospital clinicians, nurses, midwifes and physiotherapists) to CAM also seem to form a barrier. Findings from the UK [16,17,[34][35][36], Israel [9] and Switzerland [14] indicate citizens' wish for more support and knowledge about CAM from biomedical professionals. Biomedical professionals' lack of knowledge and support for citizens' interest in, and use of, CAM, as perceived by the citizens [37], may lead to non-disclosure of CAM in biomedical encounters, and constitute a significant barrier to accessing information about CAM or referrals to CAM provision via biomedical professionals.…”

Section: Citizens' Information Sources About Cammentioning

confidence: 99%

See 2 more Smart Citations

What Attitudes and Needs Do Citizens in Europe Have in Relation to Complementary and Alternative Medicine?

et al. 2012

View full text Add to dashboard Cite

Background: Surveys from several European countries suggest a European-wide increase in the use of Complementary and Alternative Medicine (CAM). To safeguard citizens’ rights concerning their healthcare, it is critical to gain an overview of citizens’ attitudes and to understand their expectations and needs regarding CAM. Methods: A review of literature was undertaken, based on systematic searches of the following electronic databases: PubMed, Web of Science, CINHAL, AMED, PsycINFO and PsycArticles; 189 articles met inclusion criteria. Articles were analysed thematically and their reporting quality assessed. Results: Despite the limited availability of research-based knowledge about citizens’ attitudes and needs concerning CAM in many European countries, some trends can be noted. Many citizens hold positive attitudes to CAM and wish for increasing access to CAM provision. Citizens call for impartial, reliable and trustworthy information to support informed decision-making, and some citizens wish for greater support and involvement of biomedical healthcare professionals in facilitating their healthcare choices. While citizens value distinct aspects of CAM practice, they are also critical consumers and support clear regulatory and educational frameworks to ensure the quality and safety of CAM provision and medicinal products. Conclusion: To gain knowledge on citizens’ needs and attitudes to CAM across Europe further research is required on 3 main issues: i) how citizens across Europe obtain information about CAM and the needs they may have for trustworthy information sources, ii) the local situations for accessing CAM and iii) citizens’ perspectives on the quality of care and safety of CAM provision and products.

show abstract

Section: Citizens' Information Sources About Cammentioning

confidence: 72%

Section: Citizens' Information Sources About Cammentioning

confidence: 99%

Section: Citizens' Information Sources About Cammentioning

confidence: 99%

See 1 more Smart Citation

What Attitudes and Needs Do Citizens in Europe Have in Relation to Complementary and Alternative Medicine?

et al. 2012

View full text Add to dashboard Cite

show abstract

“…These adverse effects generate a great deal of anxiety for physicians, patients, and families. Therefore, it is not surprising that some studies report as many as 89% of parents would give their children with IBD complementary or alternative medications such as probiotics [10]. Interestingly, this statistic is profoundly higher than reports in the adult literature, which cite complementary medication usage rates of about 50% [11].…”

Section: A Pediatric Perspectivementioning

confidence: 96%

Probiotics in pediatric inflammatory bowel diseases

Gulati

Dubinsky²

2009

Curr Gastroenterol Rep

View full text Add to dashboard Cite

The intestinal microbiota plays a key role in the initiation and perpetuation of inflammatory bowel diseases (IBD). As such, there is a strong rationale to use agents such as probiotics to modulate the gut microbiome as a treatment strategy for these disorders. Furthermore, the potential toxicities of current IBD therapies make probiotics attractive medications for patients and physicians. However, although much attention is being placed on probiotic therapy, relatively few well-designed trials have evaluated its efficacy in the management of IBD, particularly in the pediatric population. This article examines the currently available published trials studying probiotics for the treatment of IBD, with particular emphasis on their role in pediatric IBD patients.

show abstract

“…As prior enteric infections have been associated with the development of IBD, therapies that target or ameliorate the intestinal disruption brought on by antibiotic therapy seem a logical choice. In a survey of 86 children with IBD in Scotland, 44% reported that they used probiotics to control their IBD symptoms [37] . The effectiveness of probiotics for IBD has shown mixed results, depending upon the type of probiotic and the condition treated.…”

Section: Treatment For Ibdmentioning

confidence: 99%

State-of-the-art of irritable bowel syndrome and inflammatory bowel disease research in 2008

McFarland¹

2008

WJG

View full text Add to dashboard Cite

Irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) are two of the leading causes of chronic intestinal conditions in the world. This issue of World Journal of Gastroenterology (WJG ) presents a series of papers from world experts who discuss the current knowledge and opinions on these important conditions. Although great strides have been made in the diagnosis, treatment and pathology of IBS and IBD; much has yet to be explained. The etiologies and risk factors of these multifactorial conditions remain elusive. Specific diagnostic biomarkers need to be developed and safer treatments developed. The burden of IBS and IBD on the healthcare system is felt with repeated medical care visits and high costs. IBS and IBD patients can account for 30%-50% of office visits at gastroenterology services/clinics. Over one million people have IBD in the United States, with 30 000 new cases being diagnosed every year. One-quarter million people in the UK are afflicted with IBD. The cost of medical care in the United States for IBD is estimated to be $1.8 billion/year. IRRITABLE BOWEL SYNDROME (IBS)Incidence of IBS IBS is a global problem and is more common in women than men. In developed countries, the prevalence of IBS ranges from 3%-25% of adults [1][2][3][4] and in the United States, IBS affects 15 million adults [5] . In the United Kingdom, IBS affects 10%-15% of the adult population [6] . The cost of direct and indirect medical care for IBS reached over $200 billion dollars in the United States [5,7] . Diagnosis of IBSAs there are no biologic markers for IBS, the diagnosis is usually based on symptoms and exclusion of other known causes of intestinal distress [6] . Unlike IBD, IBS does not cause severe inflammation, ulcers or other structural damage that aids the diagnosis of IBD. IBS is a functional disorder characterized by abdominal bloating, flatulence, abdominal pain and bowel dysfunction. The varying nature of symptoms and lack of structural abnormalities presents a diagnostic challenge. There are three main types of disease phenotypes: diarrhea-predominant (IBS-D), constipation-predominant (IBD-C) or alternating diarrhea-constipation (IBS-A). The diarrhea-predominant type is more common (48%) in males, whereas constipation-predominant (39%) or alternating types (48%) are more common in women [1] . Several tools (for example, Rome Ⅲ, Manning criteria) have been developed to standardize the diagnosis of IBS. Most of the historic research has been focused on the pathophysiology of diarrhea, but constipation has not been as well described. The review by McCrea and colleagues in this issue summarizes our current knowledge about the physiology and pathology of constipation [8] . The prevalence of constipation ranges from 15%-25% in the general population and is more common in women than men and in ages over 70 years old [9] . The typical definition of constipation (less than three stools/week) may not be a sensitive measure for this condition, as individuals vary widely in their own bowel habits. ...

show abstract

Dietary modifications, nutritional supplements and alternative medicine in paediatric patients with inflammatory bowel disease

Abstract: SUMMARY BackgroundData on use of complementary and alternative medicine in children with inflammatory bowel disease are scarce.

Cited by 42 publications

References 52 publications

What Attitudes and Needs Do Citizens in Europe Have in Relation to Complementary and Alternative Medicine?

What Attitudes and Needs Do Citizens in Europe Have in Relation to Complementary and Alternative Medicine?

Probiotics in pediatric inflammatory bowel diseases

State-of-the-art of irritable bowel syndrome and inflammatory bowel disease research in 2008

Contact Info

Product

Resources

About